EP
RLAY icon

Essential Partners’s Relay Therapeutics RLAY Stock Holding History

Essential Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$36.6K Hold
2,026
– – 0.02% 711
2026
Q2 		$37.9K Sell
2,026
-3,332
-62% -$48.4K 0.02% 683
2026
Q1 		$53.3K Buy
5,358
+12
+0.2% +$107 0.02% 586
2025
Q4 		$45.2K Hold
5,346
– – 0.01% 637
2025
Q3 		$27.9K Buy
5,346
+186
+4% +$709 0.01% 787
2025
Q2 		$17.9K Buy
+5,160
New +$15.3K 0.01% 704

Other funds holding RLAY

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Essential Partners's RLAY Position: Q3 2026 in Review

Essential Partners held its Relay Therapeutics (RLAY) position steady in Q3 2026 at 2,026 shares worth $36.6K. The position accounts for 0.02% of the portfolio, ranked #711.

Essential Partners first reported a position in RLAY in Q2 2025 and has held it in 6 quarters since. The position peaked at $53.3K in Q1 2026. 11 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Essential Partners held 2,026 shares of Relay Therapeutics worth $36.6K as of Q3 2026.
  • Essential Partners left its Relay Therapeutics share count unchanged in Q3 2026.
  • Relay Therapeutics made up 0.02% of Essential Partners's portfolio in Q3 2026, its #711 holding.
  • Essential Partners first reported a position in Relay Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Relay Therapeutics position peaked at $53.3K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.